Terms: = Pancreatic cancer AND ITK, PSCTK2, 3702, Q08881, ENSG00000113263, EMT, MGC126258, LYK, MGC126257 AND Treatment
424 results:
1. Jolkinolide B inhibits the progression of hepatocellular carcinoma by regulating Musashi-2 protein.
Wu T; Yang H; Li J; Fang H; Shi X; Li J; Feng L
PLoS One; 2024; 19(4):e0299920. PubMed ID: 38630658
[TBL] [Abstract] [Full Text] [Related]
2. microRNA-15a-5p suppresses hypoxia-induced tumor growth and chemoresistance in bladder cancer by binding to eIF5A2.
Yang J; Xiang H; Cheng M; Jiang X; Chen Y; Zheng L; Yan S; Zhang S; Zhang C; Chen W; Chen D
Neoplasma; 2024 Feb; 71(1):60-69. PubMed ID: 38506035
[TBL] [Abstract] [Full Text] [Related]
3. FUT4 promotes the progression of Cholangiocarcinoma by modulating epithelial-mesenchymal transition.
Liu E; Qian X; He Y; Chen K
Cell Cycle; 2024 Jan; 23(2):218-231. PubMed ID: 38466946
[TBL] [Abstract] [Full Text] [Related]
4. Fundamental insights and molecular interactions in pancreatic cancer: Pathways to therapeutic approaches.
Gu M; Liu Y; Xin P; Guo W; Zhao Z; Yang X; Ma R; Jiao T; Zheng W
Cancer Lett; 2024 Apr; 588():216738. PubMed ID: 38401887
[TBL] [Abstract] [Full Text] [Related]
5. Characterization of a germline variant TNS1 c.2999-1G > C in a hereditary cancer syndrome family.
Di X; Wang D; Wu J; Zhu X; Wang Y; Yan J; Wen L; Jiang H; Wen D; Shu B; Zhang S
Gene; 2024 May; 908():148304. PubMed ID: 38387708
[TBL] [Abstract] [Full Text] [Related]
6. Anti-tumorigenic effects of naive and TLR4-primed adipose-derived mesenchymal stem cells on pancreatic ductal adenocarcinoma cells.
Kaçaroğlu D; Yaylacı S; Gurbuz N
Cancer Med; 2024 Jan; 13(2):e6964. PubMed ID: 38379331
[TBL] [Abstract] [Full Text] [Related]
7. Exosomal non-coding RNA: A new frontier in diagnosing and treating pancreatic cancer: A review.
Sha G; Zhang W; Jiang Z; Zhao Q; Wang D; Tang D
Int J Biol Macromol; 2024 Apr; 263(Pt 1):130149. PubMed ID: 38365161
[TBL] [Abstract] [Full Text] [Related]
8. Ginsenoside Rg3 suppresses vasculogenic mimicry by impairing DVL3-maintained stemness via PAAD cell-derived exosomal miR-204 in pancreatic adenocarcinoma.
Cai X; Wang Z; Lin S; Chen H; Bu H
Phytomedicine; 2024 Apr; 126():155402. PubMed ID: 38350242
[TBL] [Abstract] [Full Text] [Related]
9. Molecular mechanisms of pancreatic cancer liver metastasis: the role of PAK2.
Yang H; Li Z; Zhu S; Wang W; Zhang J; Zhao D; Zhang M; Zhu W; Xu W; Xu C
Front Immunol; 2024; 15():1347683. PubMed ID: 38343537
[TBL] [Abstract] [Full Text] [Related]
10. Deciphering the oncogenic landscape: Unveiling the molecular machinery and clinical significance of LncRNA TMPO-AS1 in human cancers.
Saraswat SK; Mahmood BS; Ajila F; Kareem DS; Alwan M; Athab ZH; Shaier JB; Hosseinifard SR
Pathol Res Pract; 2024 Mar; 255():155190. PubMed ID: 38330619
[TBL] [Abstract] [Full Text] [Related]
11. Advance in the role of chemokines/chemokine receptors in carcinogenesis: Focus on pancreatic cancer.
Song N; Cui K; Zeng L; Li M; Fan Y; Shi P; Wang Z; Su W; Wang H
Eur J Pharmacol; 2024 Mar; 967():176357. PubMed ID: 38309677
[TBL] [Abstract] [Full Text] [Related]
12. Downregulation of Roundabout guidance receptor 2 suppresses hepatocellular carcinoma progression by interacting with Y-box binding protein 1.
Liu T; Zhai C; Tian B; Li C; Han S; Wang S; Xuan M; Liu D; Zhao Y; Zhao H; Yu W; Wang J
Sci Rep; 2024 Jan; 14(1):2588. PubMed ID: 38297025
[TBL] [Abstract] [Full Text] [Related]
13. The role of histone H1.2 in pancreatic cancer metastasis and chemoresistance.
Gu J; Zhang J; Xia R; Wang X; Yang J; Xie F; Zhou Q; Li J; Zhang T; Chen Q; Fan Y; Guo S; Wang H
Drug Resist Updat; 2024 Mar; 73():101027. PubMed ID: 38290407
[TBL] [Abstract] [Full Text] [Related]
14. Machine learning identifies SLC6A14 as a novel biomarker promoting the proliferation and metastasis of pancreatic cancer via Wnt/β-catenin signaling.
Dang C; Bian Q; Wang F; Wang H; Liang Z
Sci Rep; 2024 Jan; 14(1):2116. PubMed ID: 38267509
[TBL] [Abstract] [Full Text] [Related]
15. KIF20B and MET, hub genes of DIAPHs, predict poor prognosis and promote pancreatic cancer progression.
Cao Z; Guan M; Cheng C; Wang F; Jing Y; Zhang K; Jiao J; Ruan L; Chen Z
Pathol Res Pract; 2024 Feb; 254():155046. PubMed ID: 38266456
[TBL] [Abstract] [Full Text] [Related]
16. GK921, a transglutaminase inhibitor, strengthens the antitumor effect of cisplatin on pancreatic cancer cells by inhibiting epithelial-to-mesenchymal transition.
Li M; Wang X; Chen X; Hong J; Du Y; Song D
Biochim Biophys Acta Mol Basis Dis; 2024 Feb; 1870(2):166925. PubMed ID: 38084873
[TBL] [Abstract] [Full Text] [Related]
17. Promising applications of nanotechnology in inhibiting chemo-resistance in solid tumors by targeting epithelial-mesenchymal transition (emt).
Tangsiri M; Hheidari A; Liaghat M; Razlansari M; Ebrahimi N; Akbari A; Varnosfaderani SMN; Maleki-Sheikhabadi F; Norouzi A; Bakhtiyari M; Zalpoor H; Nabi-Afjadi M; Rahdar A
Biomed Pharmacother; 2024 Jan; 170():115973. PubMed ID: 38064969
[TBL] [Abstract] [Full Text] [Related]
18. SMAD4 endows TGF-β1-induced highly invasive tumor cells with ferroptosis vulnerability in pancreatic cancer.
Chen HD; Ye Z; Hu HF; Fan GX; Hu YH; Li Z; Li BR; Ji SR; Zhou CJ; Xu XW; Yu XJ; Qin Y
Acta Pharmacol Sin; 2024 Apr; 45(4):844-856. PubMed ID: 38057506
[TBL] [Abstract] [Full Text] [Related]
19. Modeling Molecular Pathogenesis of Idiopathic Pulmonary Fibrosis-Associated Lung cancer in Mice.
Barravecchia I; Lee JM; Manassa J; Magnuson B; Ferris SF; Cavanaugh S; Steele NG; Espinoza CE; Galban CJ; Ramnath N; Frankel TL; Pasca di Magliano M; Galban S
Mol Cancer Res; 2024 Mar; 22(3):295-307. PubMed ID: 38015750
[TBL] [Abstract] [Full Text] [Related]
20. Molecular Networks of Platinum Drugs and Their Interaction with microRNAs in cancer.
Tanabe S; Boonstra E; Hong T; Quader S; Ono R; Cabral H; Aoyagi K; Yokozaki H; Perkins EJ; Sasaki H
Genes (Basel); 2023 Nov; 14(11):. PubMed ID: 38003016
[TBL] [Abstract] [Full Text] [Related]
[Next]
